YULIENNY CABRERA JIMENEZ: Open Payments
NPI 1194312561 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$800 in 45 payments from 16 companies in 2025. Trend: 2023 $199 · 2024 $851 · 2025 $800
Food & beverage: $800
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $225 |
| Novo Nordisk Inc | 4 | $97 |
| Amgen Inc. | 4 | $66 |
| Exact Sciences Corporation | 3 | $61 |
| Avvisto Therapeutics, LLC | 3 | $56 |
| Dexcom, Inc. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Paratek Pharmaceuticals, Inc. | 2 | $35 |
| Renalytix AI, Inc. | 1 | $32 |
| Averitas Pharma Inc. | 1 | $29 |
Products named: QULIPTA, Cologuard Collection Kit, CYCLOSET, Wegovy, Dexcom G6 Transmitter, UBRELVY, REXULTI, NUZYRA.
Industry payments across TX — which companies pay providers there.
